Article

SUCCESSFUL MANUFACTURING OF CLINICAL-GRADE SARS-CoV-2 SPECIFIC T CELLS FOR ADOPTIVE CELL THERAPY

2020-04-30

Abstract excerpt

<h4>SUMMARY</h4> <h4>Background</h4> Adoptive therapy with SARS-CoV-2 specific T cells for COVID-19 has not been reported. The feasibility of rapid clinical-grade manufacturing of virus-specific T cells from convalescent donors has not been demonstrated for this or prior pandemics. <h4>Methods</h4> One unit of whole blood was collected from each convalescent donor following standard blood bank practices. After the...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 944c0107-4a08-54d9-ad29-89c050c52e9d
DOI: 10.1101/2020.04.24.20077487

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

SUCCESSFUL MANUFACTURING OF CLINICAL-GRADE SARS-CoV-2 SPECIFIC T CELLS FOR ADOPTIVE CELL THERAPYDOI 10.1101/2020.04.24.20077487Read

Rapid GMP-compliant expansion of SARS-CoV-2-specific T cells from convalescent donors for use as an allogeneic cell therapy for COVID-19Semantic proximity Read

SARS-CoV-2-specific T cells generated for adoptive immunotherapy are capable of recognizing multiple SARS-CoV-2 variantsSemantic proximity Read

A Novel Cell Therapy for COVID-19 and Potential Future Pandemics: Virus Induced Lymphocytes (VIL)Semantic proximity Read

A Phase I/II Study of Adoptive SARS-CoV-2 Specific T Cells in Immunocompromised Hosts with or at Risk of Severe COVID-19 InfectionSemantic proximity Read

Dysfunctional Sars-CoV-2-M protein-specific cytotoxic T lymphocytes in patients recovering from severe COVID-19Semantic proximity Read

Rapid, simplified whole blood-based multiparameter assay to quantify and phenotype SARS-CoV-2-specific T-cells.Semantic proximity Read

Suboptimal SARS-CoV-2-specific CD8<sup>+</sup> T-cell response associated with the prominent HLA-A*02:01 phenotypeSemantic proximity Read

SARS-CoV-2 Humoral and Cellular Immune Responses in COVID-19 Convalescent Individuals With HIVSemantic proximity Read

Antibody response and intra-host viral evolution after plasma therapy in COVID-19 patients pre-exposed or not to B-cell depleting agentsSemantic proximity Read

Inflammatory Markers and Auto-Abs to Type I IFNs in COVID-19 Convalescent PlasmaSemantic proximity Read

CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity.Semantic proximity Read

Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiencySemantic proximity Read